Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35007321

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2022 May 12
First author
Mascarenhas J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Mascarenhas J
      type
      Author
    2. name
      Kosiorek HE
      type
      Author
    3. name
      Prchal JT
      type
      Author
    4. name
      Rambaldi A
      type
      Author
    5. name
      Berenzon D
      type
      Author
    6. name
      Yacoub A
      type
      Author
    7. name
      Harrison CN
      type
      Author
    8. name
      McMullin MF
      type
      Author
    9. name
      Vannucchi AM
      type
      Author
    10. name
      Ewing J
      type
      Author
    11. name
      O'Connell CL
      type
      Author
    12. name
      Kiladjian JJ
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Mascarenhas J
      type
      Author
    2. name
      Kosiorek HE
      type
      Author
    3. name
      Prchal JT
      type
      Author
    4. name
      Rambaldi A
      type
      Author
    5. name
      Berenzon D
      type
      Author
    6. name
      Yacoub A
      type
      Author
    7. name
      Harrison CN
      type
      Author
    8. name
      McMullin MF
      type
      Author
    9. name
      Vannucchi AM
      type
      Author
    10. name
      Ewing J
      type
      Author
    11. name
      O'Connell CL
      type
      Author
    12. name
      Kiladjian JJ
      type
      Author
    bibliography ids
    1. nci-bib-e963039d3525ccd896aaa97c
    book metadata
    content sha256
    35346a4d93de69b447a4f7731e3e5a6ad6e29f2e894ee30e8853e2ada3a548f7
    document type
    citation
    dois
    1. 10.1182/blood.2021012743
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:35007321
    immutable id
    pubmed:35007321@35346a4d93de69b447a4f7731e3e5a6ad6e29f2e894ee30e8853e2ada3a548f7
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    19
    name
    Blood
    nlm unique id
    7603509
    pages
    2931-2941
    volume
    139
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      35007321
      provenance
      batch id
      3f4d1914d2afe41e9e70
      provider
      NCBI PubMed ESummary
      record sha256
      44a8a2d08241cb638f873d0c8f7a974e0927f8f261bdf81bdf23a2410681359a
      response sha256
      0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
      retrieved at
      2026-09-09T23:48:06.522634+00:00
      publication date
      display
      2022 May 12
      precision
      day
      year
      2022
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Randomized Controlled Trial
      4. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/35007321/
      title
      A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia.

      Preserved source evidence · Not medical advice